All authors may have stocks/stock options in AstraZeneca
However, there are some inconsistencies in the literature, which may be attributed to differences in the disease severity, age, gender, comorbidity, the investigated brain regions, the status and duration of medications in subjects
Aminzadeh-Gohari S, Feichtinger RG, Vidali S, Locker F, Rutherford T, ODonnel M, Stger-Kleiber A, Mayr JA, Sperl W, Kofler B (2017) A ketogenic diet supplemented with medium-chain triglycerides enhances the anti-tumor and anti-angiogenic efficacy of chemotherapy on neuroblastoma xenografts in a CD1-nu mouse model
Mastaitis, J.W., et al., GDF8 and activin A blockade protects against GLP-1-induced muscle loss while enhancing fat loss in obese male mice and non-human primates
Why do some patients tolerate GLP-1 receptor agonists with ease while others discontinue early